Korian is an actor on the temporary and permanent dependency care market in France, Germany and Italy. Co. offers and develops services related to dependency through its retirement homes (116 as of Dec 31 2009), follow-up care and rehabilitation facilities (35 as of Dec 31 2009) and psychiatric clinics (11 as of Dec 31 2009). Co.'s operations can be divided into four geographical segments: Medical and Social activity in France (retirement homes); Sanitary activity in France (follow-up care, rehabilitation, psychiatry and home medical care); Italy; and Germany.
  • TickerKORI
  • ISINFR0010386334
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

Bruno de La Rochebrochard

KORIAN: Feedback RS management: A crisis that strengthens the group in its strategic choices | BUY vs. BUY - TOP PICKS | EUR48,5(+69%)

KORIAN - BUY vs. BUY - TOP PICKS | EUR48,5(+69%) Feedback RS management: A crisis that strengthens the group in its strategic choices Covid-19: impacts and potential consequences 2020 targets not invalidated and 2021 guidelines confirmed…

KORIAN SA reduced its risk exposure resulting in an upgrade to Slightly Positive

KORIAN SA (FR), a company active in the Health Care Providers industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date March 6, 2020, the closing price was EUR 38.68 and its potential was estimated at EUR 47.47.

Charles Lepetitpas ...
  • Christophe-Raphaël Ganet
  • Hana Maalej
  • Matthias Desmarais
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 03/02/2020

...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Global equities nearing potential resistance Helped by support from global central banks and improving trade headlines, critical support levels have held for major global indexes and therefore our outlook remains constructive. At the same time, just because these indexes are not breaking down does not mean they are headed higher. Rather, we believe global equities remain in a state of purgatory and consolidation is likely to continue as several major indexes approach logical resistance... see charts below and page 2. With global equity markets generally moving sideways, we want to stick with ...

Matthieu DRIOL

Analyse court terme - KORIAN : La tendance de fond est clairement orientée à la hausse.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 34,74 € et 35,50 €. La tendance serait invalidée sous le support à 27,30 €.

Matthieu DRIOL

Short term view - KORIAN : The background trend is clearly bullish.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €34.74 and €35.50. The trend would be invalidated below the support at €27.30.

Matthieu DRIOL

Analyse court terme - KORIAN : Les cours progressent toujours.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 34,74 € et 35,50 €. La tendance serait invalidée sous le support à 27,30 €.

Matthieu DRIOL

Short term view - KORIAN : Prices are still making progress.

The background trend is clearly bullish. Prices are still making progress. The following targets are at €34.74 and €35.50. The trend would be invalidated below the support at €27.30.

Bruno de La Rochebrochard

Korian: Q2 revenue: further improvement in organic growth continues with dynamic bolt-on acquisitions

Brief Comment - Korian: (BUY, Fair Value EUR33 (+12%)) Q2 revenue: further improvement in organic growth continues with dynamic bolt-on acquisitions

Bruno de La Rochebrochard

KORIAN: Feedback RS management: A crisis that strengthens the group in its strategic choices | BUY vs. BUY - TOP PICKS | EUR48,5(+69%)

KORIAN - BUY vs. BUY - TOP PICKS | EUR48,5(+69%) Feedback RS management: A crisis that strengthens the group in its strategic choices Covid-19: impacts and potential consequences 2020 targets not invalidated and 2021 guidelines confirmed…

Christophe-Raphaël Ganet

Korian : Analyst meeting: well on track

>Korian is well on track to exceed its 2020 targets - From Friday’s meeting, we retain the following points:Guidance for growth in 2020 (+9% vs +8% in 2019) should have an organic component of at least +4% (reminder: between 2014 and 2018, organic growth had never exceeded 3.8%) Korian will continue its pace of acquisitions (further bolt-on deals), while the ramp-up of openings, the effect of the pipeline (still nearly 15,000 beds despite the openings, implying ...

Christophe-Raphaël Ganet

Korian : Réunion d’analystes : sur des rails solidifiés

>Korian est bien engagé pour dépasser ses objectifs 2021 - De la réunion de vendredi, nous retenons :La croissance guidée pour 2020 (+9% vs +8% en 2019) devrait avoir une composante organique d’au moins +4% (rappel : entre 2014 et 2018, la croissance organique n’avait jamais dépassé 3,8%). Korian poursuivra son rythme d’acquisitions (poursuite des bolt-on), tandis que le ramp-up des ouvertures, l’effet du pipeline (toujours près de 15 000 lits en dépit des ouver...

Bruno de La Rochebrochard

KORIAN: FY results: A strategy that bear fruits and growth that will continue | BUY - Top Picks | EUR48,5(+11%)

KORIAN - BUY - Top Picks | EUR48,5(+11%) FY results: A strategy that bear fruits and growth that will continue Sustained results slightly ahead expectation… …with financials remaining sound 2020 outlook upwardly adjusted and confidence on 2021 expectations A valuation that remain attractive

Christophe-Raphaël Ganet

Korian : 2019 results in line – encouraging visibility – the status will probably improve - target price: € 47.5 vs € 41

>Korian posted figures in line with the guidance - Q4 sales totalled € 934,9m (+8.3%) and over the full year, revenues came to € 3 612m, i.e. +8.3% and +3.8% at constant scope and exchange rates (guidance: at least +8%e).EBITDA came in at € 948m, i.e. 26.2% of sales, and EBITA totalled € 337m, i.e. 9.3% of sales.The operating cash flow at € 231m increased by 13% and the leverage stood at around 3.1x (net debt: € 3157m). Finally, a dividend of € 0.66 (+10%) w...

Tony Lebon

Korian : Recommandation relevée à Achat sur l’ODIRNANE

Nous updatons notre recommandation sur l’ODIRNANE suite au roadshow crédit Korian que nous avons organisé dans nos locaux. - Depuis notre initiation de couverture le 19 juin dernier, le cours de l’action Korian a progressé de +12% (de 35,26 EUR à 39,40 EUR), alors que le prix de l’ODIRNANE n’a augmenté que de +4% (ask price : de 45,75 EUR à 47,75 EUR), ce qui représente un peu plus d’un tiers de la performance de l’action alors que le delta de la convertible était d’environ 50% en...

Tony Lebon

Korian : Recommendation raised to Buy on ODIRNANE bond

We are updating our recommendation on the ODIRNANE bond following the Korian credit roadshow that we organized at Oddo BHF HQ in Paris. - Since our initiation of coverage on June 19, the Korian share price has risen by +12% (from EUR 35.26 to EUR 39.40), while the ODIRNANE price has increased by only +4% (ask price: from EUR 45.75 to EUR 47.75), which represents a bit more than one third of the share's performance, while the convertible delta was around 50% in June. - Given this el...

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 23/10/2019 - Casino, BPER - Ubi Banca, Eramet- EN

Casino (O/P On Short Term Bonds, M/P On Long Term Bonds): Obtains New Secured Bank Loans, Downgrade Of Its Rating By Moody's BPER (O/P vs M/P) - UBI Banca (O/P): Rumours of A Merger Eramet (M/P): Confirms its Production Targets Softbank (M/P): $5bn Additional Funding Injected Into Wework Peugeot (O/P) - Q3-19: Revenues Up 1% To €15.6bn Crown European Holdings (M/P): Issued A €550m 3NLC 0.875% Bond Boston Scientific: 8Y Senior Unsecured Bond issue planned Akzo Nobel (M/P) - 9M19: EBITDA Of €1.0bn (+29%)

Marnik Hinnekens

TP ICAP - Europe - Morning CreditUpdate 23/10/2019 - Casino, BPER - Ubi Banca, Eramet- FR

Casino (Achat souches courtes, Conserver souches longues) : Obtention de nouvelles lignes bancaires sécurisées, dégradation du rating par Moody’s BPER (Achat) – UBI Banca (Achat) : Rumeurs de fusion Eramet (Conserver) : Confirmation des objectifs de production SoftBank (Conserver) : Injection de fonds supplémentaires de $5 mds dans WeWork Peugeot (Achat) - T3-19 : CA de €15,6 mds en hausse de 1% Crown European Holdings (Conserver) : Emission d'une obligation de €550m 3NLC 0,875% Boston Scientific : Prévoit d’émettre une obligation senior...

Tony Lebon

Korian : Un véhicule de récurrence des résultats mais correctement valorisée

>Initiation du suivi de Korian côté crédit avec une reco. Neutre - Nous adoptons une recommandation Neutre sur l’ODIRNANE Korian call 2023. Même si nous apprécions le caractère récurrent des revenus et de la rentabilité de l’émetteur, l’ODIRNANE est à sa fair value en spot aujourd’hui et l’upside en prospectif est limité sur la base du TP de notre analyste equity. Toutefois, nous n’excluons pas, pour notre part, un retour (timing incertain) de la thématique ...

Charles Lepetitpas ...
  • Christophe-Raphaël Ganet
  • Hana Maalej
  • Matthias Desmarais
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 03/02/2020

...

Charles Lepetitpas ...
  • Christophe-Raphaël Ganet
  • Hana Maalej
  • Matthias Desmarais
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 02/03/2020

...

Alain William ...
  • Alfred Glaser
  • Baptiste Lebacq
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 02/28/2020

...

Alfred Glaser ...
  • Baptiste Lebacq
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 28/02/2020

...

Anis Zgaya ...
  • Christophe-Raphaël Ganet
  • Fatma Agnès Hamdani
  • Khaled Ben Amor
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 02/10/2020

Scandic Hotels is the leading player in the Nordic hotel sector. The group boasts a broadly positive track record in terms of development and growth although its profitability continues to lag behind that of its peers. The outlook is fairly mixed and the lack of clear catalysts prompts us to take a cautious stance on the stock. We are initiating coverage with a Neutral rating and a target price of SEK 98. - Cf. equity report published today. - ...

KORIAN SA reduced its risk exposure resulting in an upgrade to Slightly Positive

KORIAN SA (FR), a company active in the Health Care Providers industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date March 6, 2020, the closing price was EUR 38.68 and its potential was estimated at EUR 47.47.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Korian - Assemblée générale des actionnaires du 06 juin 2019

RémunérationsPar rapport à la précédente politique de rémunération, en termes de montants et de structure, la société ne propose aucune modification. Cependant, elle améliore sa communication puisqu’elle décrit (dans un communiqué publié sur son site) la nature des critères qualitatifs qui seront utilisés dans le cadre du bonus, ce qu’elle ne faisait pas précédemment. Par ailleurs, elle a ajouté un critère RSE à son bonus 2019 (conformément aux recommandations du code Afep/Medef révisé en juin 2018 auquel la société se réfère), ce que l’on appréciera. Ces changements sont positifs. Aussi, nous...

Jehanne Leroy

Proxy Report - 14/06/2018

La politique de rémunération de Mme Boissard souffre toujours d’une faiblesse significative : la rémunération actionnariale soit basée sur des conditions de performance qui ne sont pas mesurées sur le long-terme (3 ans minimum). Cependant, la société a mis en place pour la politique de rémunération 2018 2 améliorations significatives concernant le plafonnement de la rémunération long-terme et celui des rémunérations exceptionnelles. Aussi la politique de rémunération 2018 semble préférable à celle mise en place pour 2017 et nous soutenons donc la nouvelle politique (résolution 7). Cependant, ...

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch